Cargando…

Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression

Vascular endothelial growth factor (VEGF) is an important factor mediating tumour angiogenesis. VEGF mRNA is differentially expressed in bladder cancer with high expression in superficial tumours (stage pT(a)and pT(1)) contrasting with low expression in muscle invasive tumours (stage ≥ pT(2)). To in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crew, J P, Fuggle, S, Bicknell, R, Cranston, D W, Benedetti, A de, Harris, A L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363195/ https://www.ncbi.nlm.nih.gov/pubmed/10638984 http://dx.doi.org/10.1054/bjoc.1999.0894

Ejemplares similares

Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasion
por: Fujiyama, C, et al.
Publicado: (2001)

High expression of Wnt7b in human superficial bladder cancer vs invasive bladder cancer.
por: Bui, T. D., et al.
Publicado: (1998)

p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours
por: Le Frère-Belda, M A, et al.
Publicado: (2001)

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo
por: Zhang, H-T, et al.
Publicado: (2000)

Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma
por: Brown, N S, et al.
Publicado: (2005)

Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas
por: Yudoh, K, et al.
Publicado: (2001)

Vascular endothelial growth factor expression is independent of hypoxia in human malignant glioma spheroids and tumours
por: Parliament, M B, et al.
Publicado: (2000)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
por: Ord, J J, et al.
Publicado: (2005)

The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer
por: Turner, K J, et al.
Publicado: (2002)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Eukaryotic initiation factor 6 regulates mechanical responses in endothelial cells
por: Keen, Adam N., et al.
Publicado: (2022)

Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.
por: Scott, P. A., et al.
Publicado: (1998)

Mutant epidermal growth factor receptor enhances induction of vascular endothelial growth factor by hypoxia and insulin-like growth factor-1 via a PI3 kinase dependent pathway
por: Clarke, K, et al.
Publicado: (2001)

Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix
por: Loncaster, J A, et al.
Publicado: (2000)

Assessment of angiogenic factor, vascular endothelial growth factor, serum and urine level changes in superficial bladder tumor immunotherapy by intravesical Bacillus Calmette-Guerin
por: Kerigh, Behzad Feizzadeh, et al.
Publicado: (2010)

Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver metastasis vascularity and volume
por: Davies, M M, et al.
Publicado: (2000)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas
por: Fontanini, G, et al.
Publicado: (1999)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors
por: Shaheen, R M, et al.
Publicado: (2001)

Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers
por: Fujimoto, J, et al.
Publicado: (2001)

Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer
por: West, A F, et al.
Publicado: (2001)

Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer
por: Eroğlu, A, et al.
Publicado: (1999)

Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
por: Akagi, K, et al.
Publicado: (2000)

Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β
por: Akagi, Y, et al.
Publicado: (1999)

Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer
por: Coradini, D, et al.
Publicado: (2001)

Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
por: Fujimoto, J, et al.
Publicado: (1999)

Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells
por: Chen, H J, et al.
Publicado: (2000)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
por: Tilborg, A A G van, et al.
Publicado: (1999)

Phosphorylation Stoichiometries of Human Eukaryotic Initiation Factors
por: Andaya, Armann, et al.
Publicado: (2014)

Tissue factor, osteopontin, α(v)β(3) integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression
por: Takano, S, et al.
Publicado: (2000)

The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer
por: Kajita, T, et al.
Publicado: (2001)

Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis
por: Rofstad, E K, et al.
Publicado: (1999)

The utility of tumour markers in assessing the response to chemotherapy in advanced bladder cancer
por: Cook, A M, et al.
Publicado: (2000)

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer
por: Hashimoto, I, et al.
Publicado: (2001)

Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells
por: Pidgeon, G P, et al.
Publicado: (2001)

Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia
por: Allalunis-Turner, M J, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_fa99bmsvmcro160i48dscf4r5e